Markets live chat transcript for the chat ending at 12:09 on 19 May 2009. Participants in this chat were: Neil Hume, FT (NH) Bryce Elder (BE)
The primary difference between our forecast and the reported results looks to
be a £9m lower International EBIT outturn following a -400bp 2H International
EBIT margin fade. This PBT performance drove EPS of 28p, -35% yoy (Citi
27.9p). As pre-announced full year UK LFL sales fell -5.9% (Gen Merchandise
-6.9% and Food -5.0%), alongside a -170bp UK gross margin declined.
dividend has been reduced, albeit the -33% 2H reduction to 9.5p is less
aggressive than our -50% forecast. This brings the full year DPS to 17.8p (Citi
15.4p). Management also propose cutting 1H 2009/10 DPS by -33% to 5.5p,
arguing for a 15p March 2010 DPS forecast.
partnership classification (Citi £3bn) — These changes make the annual
distributions to the pension scheme at the discretion of the Group from
2010/11 onwards. This reclassifies £539.6m from net debt to equity, and
reduces the March 2010 p&l finance charge by c£30m.
across the sector, April and early May trading patterns have continued the
better 4Q 2008/9 trend at M&S, with LFL sales patterns over the last 7 weeks
broadly in line with the Easter adjusted 4Q LFL sales trends (-3.5%).
Specifically, M&S are guiding for a -125bp to -175bp gross margin fade this
year (Citi -80bp), cost -1% (Citi -1.5%), capex £400m (Citi £400m), space
+3% (Citi +2.5%), and pension finance income of £12m (Citi £33m).
back of these results we expect consensus March 2010E to remain unchanged
at c£480m, EPS 22p (-21.5% yoy).
What does it all mean? — While the dividend cut was largely expected, the
modestly reduced space, gross margin and cost guidance, and the absence of
any earnings upgrade, could weigh on the shares in the wake of the recent
share price outperformance.
move far on the back of these results but, for our part, we factor in an improved LFL
expectation and lower interest charge. This sees us raise our Mar-10 PBT forecast to
£524m (24.3p) from £482m (22.0p). On 14x Mar-10 earnings, M&S is trading at a
premium to the sector which is, in our view, undeserved. Targetting 12x 2010 earnings,
we move our TP to 290p. Reduce.
year, in keeping with KBC forecasts. As anticipated, the
final dividend has been cut, although less than expected.
Trading on 8.2x 2008 peak earnings, Marks & Spencer
shares are factoring in too much potential for recovery
overheads expected to be down 1%, in keeping with our forecast assumptions
and gross margin down 125-175bps, more optimistic than our 220bps forecast.
At this stage, we did not expect to change our £494m PBT forecast for 2010E.
Net debt down to £2.5bn due to pension reclassification. Net debt has fallen
substantially from £3.1bn against forecast expectations of a modest rise.
However, this improvement is almost entirely due to the reclassification of the
pension scheme partnership as an ‘equity instrument’, which we assume to be
purely window dressing, with no change to the underlying liability of £572m.
Take profits. Recent trading conditions have been better than anticipated for the
retail sector and apparel in particular, points that will become apparent in the
next trading update for M&S. With a growing international business, freehold
backing and scope for margins to stabilise, we can see the ‘bull case’ for Marks
& Spencer. However, the shares are now trading on 8.2x 2008 peak earnings, a
position that may take another five years to recover. On that basis, we prefer
both Next and Debenhams for apparel exposure.
2009 (KBWe €365mn) and EPS of €0.30 (€0.31), with the delta coming from
higher impairment levels than we had anticipated. The underlying quality of
the results was weaker than we had expected, supported by continued strong
performance in Capital Markets in 2H08. However, stronger than forecast
capital ratios (equity tier 1 6.2% vs KBWe 5.7%) and the announcement of a
€1.4bn debt tender offer should be well received. BKIR is now trading at
c0.2x current NAV. However, we still have no indication as to the scale of
portfolios/ level of discount to be applied to loans included in NAMA.
Moving forward, the stock will be driven by the level of dilution to existing
ordinary shareholders from further equity issuance, which for the time being
remains an unknown.
exceptionals of €€ 332m ahead of our €€ 113m
• The beat was mainly due to lower costs which were €€ 2022m vs our €€ 2176m, revenue and impairment in line with expectations
• The company has now raised the impairment forecast over 3 years to €€ 6bn with downside risk – they had previously guided
€€ 4.5bn, this shouldn’t come as a massive surprise after AIB increased its impairment guidance last week. Note also the
impaired loans increased from 131 bps as at September to 393bps as at March 2009.
• Capital ratios slightly better than expected – total tier 1 at 12% vs our 11.2%, equity 6.2% vs our 5.8% – note also the Tier 1
debt repurchase which was announced today and we estimate that this could generate up to €€ 1bn in capital (85bps) based on
50% exchange ratio and 65% take up.
• Loan deposit ratio increased from 159% as at Sept to 161%
• TNAV collapsed to €€ 3.02 vs our €€ 4.55 due to higher negative AFS & FX reserves vs our forecasts and vs interims.
• Conclusion – mixed set of results with operating performance better than expected but revenues likely to be under pressure
going forward as the company runs down the loan to deposit ratio. The tier 1 debt repurchase will be well received but this
capital is insufficient to sufficiently plug hole that impairment could cause over next few years. Negative news here is the
increase in impairment guidance and increased NPLs, which should have been expected, and the collapse in TNAV is
particularly notable. On balance, stock likely to be slightly down, especially after recent run in stock.
• On our sensitivity analysis this would give a March 2012E TNAV range of €€ 0.43 to €€ 0.78 (stressed to base) based on our
assumption of a €€ 22bn loan transfer to NAMA at 25% discount, followed by a recapitalisation to 5% equity tier 1 (this assumes
conversion of govt ref at a 20% discount to current share price and the gain from the debt repurchase). We remain
Underperform.
line our €67mn underlying estimate (including c.€390mn goodwill
impairment and restructuring costs). This implies a €511mn loss, vs. our
€503mn estimate. Net operating income of €1.85bn (-12.6% yoy) was 6%
below our estimates. Divisionally, Ireland was unsurprisingly the worst
performer (€20mn FY profit vs. €306mn estimate), offset by capital
markets.
• Revenues of €3,957mn (-7.5% yoy ) are 3% below expectations. Top line
(+12.5% yoy) largely in line, miss comes from non-interest income
(€287mn vs. €414mn estimate), with BOI claiming (i) €46mn impairments
on properties, (ii) €117mn negative insurance variance, and (iii) €66mn cost
attached to Govt. guarantee
• Excluding restructuring expenses, underlying costs of €2.0bn (-6.0%
yoy) was 4% below expectations, highlighting BOI’s cost cutting focus at
this point (through 5% yoy staff reduction and lower compensation levels).
On a sequential basis, costs declined 5% vs. H1 levels.
• Asset quality – with the loan book declining 6% vs. H108 levels, BOI
disclosed NPL ratio of 3.91% (vs. 1.31%), following a 179% hoh increase.
Provisions of €1.44bn represent 211bps of loans and came above our
€1.36bn estimates. Total “watch loans” (including past due but not impaired)
stand at €11.1bn (vs. €6.3bn in Sept), implying a 8.3% ratio (vs. 4.4%). By
segments, CRE accounted for the largest deterioration (€3.5bn NPLs,
c.1000bps provision), though we also witnessed a significant increase of
SME/corporate delinquencies (€1.2bn vs. €506mn a year before, some
320bps provisions).
• Capital – core Tier 1 ratio of 9.5% (6.2% excluding €3.5bn govt. pref
injection) is largely stable vs. H108 levels, with 9% decline of RWA levels
offsetting the c.€500mn loss
• Outlook – 3-year provisioning target of €4.5bn (set out in Feb’s IMS) now
increased to €6bn (we are already there in our estimates)
• Overall, results confirms our views for BOI (i) in absolute terms, the bank
remains immersed in a very challenging situation, with €6bn accumulated
credit charges and costs attached to govt’s preference shares implying the
bank will remain in loss making territory in 09-10E, (ii) more positively,
today’s results do not represent incrementally negative news vs. our
forecasts; this a marked difference vs. AIB’s IMS last week, with BOI
appearing as a safer option given its lower developer exposure (€12bn vs.
€23bn). In any case, and though the stock should probably be boosted by the
absence of disasters in H2, we need details on the ‘bad bank’ structure to
express a fundamental view on the two Irish banks.
Key is the outlook for 2009/10 with the company guiding to a wider than usual range of £11.0-11.8bn for operating profit which compares on a like-for-like currency basis to our forecast of £11.99bn (cons: £11.9bn). For FCF guidance is £6.0-6.5bn compared to our forecast of £6.1bn in line with cons . With revenue under pressure in Europe and FCF guidance relying on a year end swing in the dividend from VZW we expect this to be taken modestly negatively initially.
range (£11.4bn), there is even scope to see some small EPS upgrades to 15.0-15.5p reflecting lower tax and interest charges. Underlying free cash flow unchanged although estimates may still increase by 3% to reflect the phasing of a £200m tax distribution from Verizon Wireless.
mid-point is £250m above consensus (4%), £250m below our estimate and
10% above 2009. Long-term guidance of £5-6bn p.a. is too low, in our view.
£200m of tax distributions from the US have been delayed into 2010.
2010 Profit Guidance: EPS stable? — Operating profit guidance at the midpoint
is £400-500m below consensus (4%), £500m below our estimate and 4%
below 2009 levels. Detailed tax and interest commentary is consistent with
small changes only to 2010E EPS consensus.
negative in 4Q09. Sales in Europe fell (3.3)% in 4Q09, twice the rate of the
previous quarter. The pressure is widespread and reflects lower MOUs. Our
first picture shows Vodafone often in line with competitors.
Current Margin Trends in Europe — Group margins fell 1.5pp in 2H09. We see
little deterioration in margin trends in mobile and common functions compared
to 1H09, but 1pp of pressure more from fixed and recent acquisitions.
Vodafone needs to re-explain its fixed-line strategy and targets.
revenue growth comes at lower margins (25% in 2H09). Turkish EBITDA fell
37% in 2009. Vodacom and Egypt remain strong.
Immediate Outlook Difficult — Although FCF consensus should rise this is a
low-quality FCF upgrade. Indeed operating trends are poor enough in several
countries to mean the market may take the lead from operating profit
(pressure) and earnings (little need to change post lower tax and interest).
Reiterate Sell rating based on deteriorating trends and structural risks still on the horizon.
The rumour was generated after Schroders, BPP’s largest shareholder with a stake of around 17.4%, was last week reported to have said it would be interested in hearing from Pearson. The report said that earlier this year Pearson had been poised to acquire an unnamed UK-listed training company but that talks had broken off. Pearson, the owner of Mergermarket group, declined to comment.
Three weeks ago, BPP announced it had received an indicative GBP 6.20 per share offer from Apollo Global. Shares in the company are currently trading at 560p. The company went ex-div on 8 May.
It is understood that at the time of the announcement, the proposed bid, which values BPP at around GBP 300m, was viewed as a fair and full price. It was also said the approach was subject to further due diligence.
Washington Post Company’s education and training subsidiary Kaplan, which is understood to compete with BPP in several business areas, would face regulatory issues should it consider a bid, it was said.
biggest commodity-trading company, posted a 69 percent drop in
first-quarter profit after metal and energy prices fell.
Net income before attribution to shareholders and adjusting for
minority interests slid to $444 million from $1.42 billion a year
earlier, the Baar, Switzerland-based company said in a report obtained
by Bloomberg News. Sales declined 50 percent to $20 billion.
credit rating cut to the lowest investment grade in December by Standard
& Poor’s because of plunging metal prices. The employee-owned company
said in March that senior staff agreed to delay future termination
payments until at least January 2012 in an attempt to strengthen its
finances.
The company doesn’t publicly disclose information about its
financial performance on a quarterly basis, spokesman Marc Ocskay said
today in an e-mail.
output was suspended at the country’s Iscaycruz zinc mine. Zinc for
immediate delivery on the London Metal Exchange averaged $1,183 a metric
ton in the first quarter, 52 percent lower than a year earlier. Copper
and aluminum, which Glencore also produces, dropped 56 percent and 50
percent respectively.
Glencore sold the Prodeco coal assets in Colombia to Xstrata Plc
for $2 billion in March 3, using the proceeds to participate in Zug,
Switzerland-based Xstrata’s 4.1 billion- pound ($6.3 billion) rights
offer. Glencore is the largest investor in Xstrata, which reduced
ferrochrome and nickel production after prices fell and said in January
it wouldn’t pay a final dividend.
recapitalisation risk, but elsewhere problems appear to be accumulating. There are huge
unanswered questions on succession and strategy given that the head of UK job has never
been filled, and given the planned retirement of group CEO Sir Sandy Crombie. The core UK
life operation appears to be struggling, judging by a 25% fall in new business profit in 2008
and a 30% fall in sales in Q109. Making good customer losses in “cash” funds cost
shareholders some £270m in 2008. Standard Life Bank has become even more dependent
on group support and faces deteriorating credit quality, albeit from very low default rates. If
financial market recovery continues, then a solvent balance sheet will become less rare.
However, few competitors have as many operational or management questions, and the
premium rating should evaporate, in our view. UNDERPERFORM.
successor to longstanding group CEO Sir Sandy Crombie’s is now being sought, but “there is no
fixed timetable”. Given that the group has yet to fill the head of UK role vacated by Trevor
Matthews in January 2008 we do not expect to hear of Crombie’ successor any time soon.
March 9th), suggesting an appetite for further change at the top of the group.
This means that the leadership at both group level and within the group’s biggest division is an
unknown quantity, and second guessing strategic direction is more difficult than normal. We would
highlight the following issues as being critical for Sir Sandy’s eventual successor, if one is ever
found:
dependent on continued pension tax relief and benign investment market conditions. Neither
can be relied on at present, in our view.
The international operations are an accident of Standard Life’s history rather than the result of a
conscious decision as to which markets will be most attractive in future. None of the non UK
operations has performed particularly well over the last decade.
Except for Standard Life Investments, the non insurance operations have yet to establish
standalone critical mass. Standard Life Bank is particularly problematic given the liquidity crisis
and its need for financial support from the life fund at each of the last two year ends. Even SLI’s
profile has been harmed by recent problems with two cash funds.
The remaining internal candidates to succeed Crombie are David Nish (CFO, Scottish, 48) and
Keith Skeoch (head of SLI, English, 52). Neither is a “Standard lifer”, with Nish joining in 2006 and
Skeoch in 1999. Although closely associated with the problematic bid for Resolution, Nish has
otherwise been a solid performer. Skeoch has stronger operating credibility, given the emergence
of SLI as a serious standalone player under his leadership, notwithstanding recent problems with
cash funds. However, neither has direct operational life insurance experience, which could be a
concern, particularly in the absence of a head of UK life.
of underperformance against the wider insurance sector, as investors
have we believe switched from more defensive names such as RSA into
higher beta names within the sector (SXIP up 30% since 24 March,
RSA down 7%). We believe this has created a buying opportunity for
RSA, with the market price missing the attractive distribution in the
Nordic market.
the UK (only 11% of premiums) means it is better placed than peers in
our opinion, and will be able to sustain lower combined ratios.
subsidiary Codan. In our opinion, the market undervalues this asset as
part of the group. By comparing to peers Topdanmark and TrygVesta,
the remaining business is valued at a large discount to book value (30%)
based on similar metrics.
lower P/NAV (1.1x) than ZFS (1.2x ’09E), Amlin (1.3x ’09E) and
Hiscox (1.4x ’09E). We expect there is around £260m remaining stock of
reserve releases within the UK business not included in the book value.
with investment income similar to 2007 levels. We believe management
should easily meet the target of matching 2007 investment income, due
to the wide spreads now available on AA bonds (approx 5.2%).
benefit, we also believe improving yields would be positive. We expect
management to move the hold co to Ireland, following domestication of
the Irish branch, but have not allowed for the tax benefit associated with
this in our model.
on a UBS adj. basis. Concurrently we are downgrading our rating on Rolls to Sell (from Neutral).
Our new estimates factor a weaker A380 delivery outlook, a downward revision to the pension
finance charge (following publication of the annual report) and the impact of the US$ weakening
from US$1.40 to US$1.50. Our estimates are now c10% below consensus in 2010 and 2011.
We expect profits to fall at Rolls-Royce for two consecutive years in 2009 and 2010 given the
weak state of the civil aerospace OE cycle and aftermarket. Consensus expects PTP to grow in
2010. We also expect cash outflows from the group over each of the next two years as working
capital gets pressured from customers and suppliers and as customer financing becomes more
prevalent.
On our estimates Rolls is trading on a 2010e EV/EBITA of 11x – the very top of the normal
sector range and a P/E of 16x. Despite our view that 2010 will likely mark trough earnings, we
believe Rolls’ valuation is too rich given the prospect of the market revising down earnings
expectations and the need for an accounting related discount – an issue which may gain
relevance as cash generation weakens.
Valuation; Maintaining 280p price target
Our 280p PT is predicated on Rolls trading on a 2010 EV/EBITA of 9.6x, towards the middle of
the normal 9-11x forward sector trading range.
extensive hard work, the soil must be turned allowing defunct companies to
rot and provide nutrients for the next harvest. Rocks and bad seeds must be
removed allowing the next plant to grow without restrictions.
‘green shoots’. The future of these green shoots is seriously at risk. The soil in
which they are growing is so full of government stimulus fertilizer that this may
well burn the seed. The plants are watered with so much TARP liquidity that
the seeds are at risk of rotting. Should any of these survive, the regulatory
pesticides used on them will completely alter the taste of their fruits and they
will be ill-equipped to defend themselves against competitive elements in the
real world. The government is trying to grow genetically-modified companies
which might offer a short-term yield but the long term inflationary damage to
the environment has yet to be seen. In the end, these green shoots are simply
just weeds – time to do some weed whacking!
long time. They have been grown year after year to the point that pathogens
(credit default) and pests (Ponzi schemes) became abundant. Crop rotation is
now necessary and the most fertile ground will be found in the defensive
sectors and Resources.
The Office for National Statistics said consumer prices rose just 0.2 percent last month, taking the annual rate down to 2.3 percent from 2.9 percent in March — the lowest since January 2008 and below the 2.4 percent expected by analysts.
The broader RPI measure of inflation, which includes falling mortgage interest payments and is used in many wage and benefit agreements, fell to -1.2 percent, the lowest since records began in June 1948.
CPI remains above the Bank of England’s 2 percent target but policymakers expect further sharp declines in inflation as the economy is on track to shrink at its fastest since World War Two this year, and are more focused on reviving growth.
Utility and petrol prices were both lower than a year ago. Food price inflation is finally
slowing; the annual rate of food price inflation eased to 9.2% from 11.3% in March.
Some of the weakness in other components was temporary, arising from the fact that the
Budget was delivered relatively late this year and thus tax increases will raise prices a month
later than they did last year. This temporarily depressed inflation in alcohol, cigarettes and
restaurants and hotels. But some of the strength in prices over the past couple of months,
particularly in games and toys, was unwound. It seems that the decline in sterling is putting
upward pressure on final goods prices, but retailers are struggling to make price increases stick.
pressure on both measures of inflation, although this will be limited by the recent drift up in
commodity prices, and the delayed impact of tax increases. Lower interest payments will be
the dominant force driving RPI deflation to -2.7% by September. However, after this lull we
expect a swift turnaround in inflation on both indices as base effects from energy and food
drop out of the annual calculation, and nominal demand strengthens leading to upward
pressure on core prices. We expect RPI of 4.6% in December 2010.
The Speaker decided to bow to his critics and announce his departure after enduring a battering in the press over his defiant statement on Monday. It is unclear whether Mr Martin will go immediately or stay on until the general election
Mr Martin was due to meet with all the party leaders at 4pm on Tuesday to explore options for expenses reform. Some senior MPs speculated that Gordon Brown privately withdrew his support before the gathering, leaving Mr Martin with little option but to resign.
Senior MPs from all three main parties broke with centuries of tradition on Monday calling for the Speaker to resign. About 20 backbenchers have signed a motion of no confidence in the Speaker, which they hoped to debate in the Commons and bring to a vote.
Mr Martin offered an apology during the statement. But many MPs and ministers thought he misjudged the mood of the Commons and wasted a last opportunity to hold on to his job.
Before the reports of Mr Martin’s resignation, Mr Cameron said his departure would do little to assuage public anger over expenses.
confirming the strategic progress which the company continues to make.
Total turnover, at £1.6bn, was 4.3% ahead of our estimates, with all segments
ahead. Costs, too, were a bit higher than we had expected, at £1.26bn (vs.
£1.18bn e). Net income was modestly better than our estimates, at -£24m (vs. -
£26me), and with other income and associates both a bit better than we were
looking for, overall PBT pre goodwill ended up at £346m, 1.6% below our
estimates, but in the midst of ICAP’s preclose guidance. A lower tax charge and
a modestly lower share count led to eps ex exceptionals and goodwill coming in
0.8% ahead of our modestly above consensus estimates, at 34.1p. The dividend
moved up in line with eps, a fraction lower than our expectations, and came in at
17.05p.
£6m ahead and voice £2m lower.
Two additional pieces of disclosure struck us as important. Firstly, ICAP provided
some data on its post trade businesses, which generated £87m of revenue and
£43m of operating profit in FY 09 (presently, these are bracketed with electronic
in the company’s disclosure). Thus, the post trade businesses are not only
profitable, but high margin, in spite of Traiana’s still nascent operations.
and in integrating acquisitions, which depressed the operating margin by around
2%. To put it another way, the company could have outperformed expectations
considerably had it not chosen to invest for future growth. In addition, ICAP has
continued to spend heavily on technology, spending 11% of revenue on
technology development in the year.
In our view, this is a key strategic positive for the company. It has consistently
operated with a view to future growth, rather than maximising current profitability,
and it has maintained this approach even in the current difficult circumstances.
The company’s comments on OTC regulation are unsurprising but sensible, with
ICAP underlining the steps made to increate the robustness of the OTC market,
and the extensive nature of OTC clearing.
Overall, we would see ICAP’s results as encouraging, but not very surprising, and
we are unlikely to do much with our estimates. We continue to like the company
as it is using its market leadership to enable it to invest in future growth areas.
We think its strategic positioning fits excellently with current conditions, and
reiterate our Buy recommendation.
